These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. Canals M; Burgueño J; Marcellino D; Cabello N; Canela EI; Mallol J; Agnati L; Ferré S; Bouvier M; Fuxe K; Ciruela F; Lluis C; Franco R J Neurochem; 2004 Feb; 88(3):726-34. PubMed ID: 14720222 [TBL] [Abstract][Full Text] [Related]
45. In vivo dopaminergic and behavioral responses to acute cocaine are altered in adenosine A(2A) receptor knockout mice. Wells L; Opacka-Juffry J; Fisher D; Ledent C; Hourani S; Kitchen I Synapse; 2012 May; 66(5):383-90. PubMed ID: 22213208 [TBL] [Abstract][Full Text] [Related]
46. Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal. Marcellino D; Roberts DC; Navarro G; Filip M; Agnati L; Lluís C; Franco R; Fuxe K Brain Res; 2007 Apr; 1143():208-20. PubMed ID: 17320828 [TBL] [Abstract][Full Text] [Related]
48. GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation. Joffe ME; Vitter SR; Grueter BA Neuropharmacology; 2017 Jan; 112(Pt A):172-180. PubMed ID: 27012890 [TBL] [Abstract][Full Text] [Related]
49. cAMP-producing chemogenetic and adenosine A2a receptor activation inhibits the inwardly rectifying potassium current in striatal projection neurons. Wang Q; Zhou FM Neuropharmacology; 2019 Apr; 148():229-243. PubMed ID: 30659840 [TBL] [Abstract][Full Text] [Related]
50. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. González S; Cascio MG; Fernández-Ruiz J; Fezza F; Di Marzo V; Ramos JA Brain Res; 2002 Nov; 954(1):73-81. PubMed ID: 12393235 [TBL] [Abstract][Full Text] [Related]
51. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission. Tozzi A; Tscherter A; Belcastro V; Tantucci M; Costa C; Picconi B; Centonze D; Calabresi P; Borsini F Neuropharmacology; 2007 Nov; 53(6):783-9. PubMed ID: 17889039 [TBL] [Abstract][Full Text] [Related]
52. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Bubar MJ; Cunningham KA Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040 [TBL] [Abstract][Full Text] [Related]
53. Revealing Adenosine A Fernández-Dueñas V; Gómez-Soler M; Valle-León M; Watanabe M; Ferrer I; Ciruela F Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340557 [No Abstract] [Full Text] [Related]
54. The genetic epidemiology of substance use disorder: A review. Prom-Wormley EC; Ebejer J; Dick DM; Bowers MS Drug Alcohol Depend; 2017 Nov; 180():241-259. PubMed ID: 28938182 [TBL] [Abstract][Full Text] [Related]
55. Diversity and bias through dopamine D2R heteroreceptor complexes. Borroto-Escuela DO; Fuxe K Curr Opin Pharmacol; 2017 Feb; 32():16-22. PubMed ID: 27838588 [TBL] [Abstract][Full Text] [Related]
56. Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach. Jastrzębska J; Nowak E; Smaga I; Bystrowska B; Frankowska M; Bader M; Filip M; Fuxe K Neuropharmacology; 2014 Jun; 81():318-26. PubMed ID: 24632528 [TBL] [Abstract][Full Text] [Related]
57. A critical role of striatal A2A R-mGlu5 R interactions in modulating the psychomotor and drug-seeking effects of methamphetamine. Wright SR; Zanos P; Georgiou P; Yoo JH; Ledent C; Hourani SM; Kitchen I; Winsky-Sommerer R; Bailey A Addict Biol; 2016 Jul; 21(4):811-25. PubMed ID: 25975203 [TBL] [Abstract][Full Text] [Related]
58. Increased sensitivity in the interaction of the dopaminergic/adenosinergic system at the level of the adenylate cyclase activity in the striatum of the "weaver" mouse. K B; V T; N P; M M; N M; F A Neurochem Int; 2016 Oct; 99():233-238. PubMed ID: 27498335 [TBL] [Abstract][Full Text] [Related]
59. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909. Rothman RB; Glowa JR Mol Neurobiol; 1995; 11(1-3):1-19. PubMed ID: 8561954 [TBL] [Abstract][Full Text] [Related]
60. Exercise exerts an anxiolytic effect against repeated restraint stress through 5-HT Leem YH; Jang JH; Park JS; Kim HS Psychoneuroendocrinology; 2019 Oct; 108():182-189. PubMed ID: 31248747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]